Suppr超能文献

在管理式医疗人群中将SF-12映射到HUI3和视觉模拟量表。

Mapping the SF-12 to the HUI3 and VAS in a managed care population.

作者信息

Sengupta Nishan, Nichol Michael B, Wu Joanne, Globe Denise

机构信息

Center for Pharmaceutical Appraisal and Outcomes Research, Abbott Lab, Lake Bluff, Illinois, USA.

出版信息

Med Care. 2004 Sep;42(9):927-37. doi: 10.1097/01.mlr.0000135812.52570.42.

Abstract

BACKGROUND

Transforming generic health-related quality of life (HRQOL) instruments to a summary utility index is useful for deriving quality-adjusted life years (QALY) in any cost/QALY analysis.

OBJECTIVE

The purpose of this study was to investigate the role of the SF-12 in predicting utility scores derived from Health Utility Index (HUI3) and Visual Analog Scale (VAS).

METHOD

Data were obtained from a survey of 6923 managed care patients in the United States, aged 18 to 93 years, selected by strata of medication usage (at least 1 medication in target year, 5 or more medications, target medications, and both). The SF-12 was used to assess self-reported HRQOL. Utility was measured by the HUI3 and a VAS. The SF-12 items were used to predict HUI3 and VAS scores using ordinary least square regressions, with sociodemographic covariates. A second model entered each SF-12 item as categorized responses. A third model used the Physical Composite and Mental Composite scores to predict HUI3 and VAS scores.

RESULTS

The SF-12 items and sociodemographic covariates accounted for 35% to 55% of the variations in HUI3 and VAS scores, respectively. Age and most SF-12 items were significantly (P < 0.0001) associated with both utility scores in all 3 models.

CONCLUSIONS

This research provides support that an algorithm can be derived from the SF-12 to estimate utility scores based on the HUI3 and VAS for studies in populations where utility has not or cannot be measured directly.

摘要

背景

将通用的健康相关生活质量(HRQOL)工具转化为综合效用指数,对于在任何成本/质量调整生命年(QALY)分析中得出QALY很有用。

目的

本研究的目的是调查SF-12在预测从健康效用指数(HUI3)和视觉模拟量表(VAS)得出的效用分数方面的作用。

方法

数据来自对美国6923名管理式医疗患者的调查,年龄在18至93岁之间,按用药情况分层选取(目标年份至少使用1种药物、5种或更多药物、目标药物以及两者都用)。SF-12用于评估自我报告的HRQOL。效用通过HUI3和VAS进行测量。使用普通最小二乘法回归,并纳入社会人口统计学协变量,用SF-12项目预测HUI3和VAS分数。第二个模型将每个SF-12项目作为分类反应纳入。第三个模型使用身体综合得分和心理综合得分来预测HUI3和VAS分数。

结果

SF-12项目和社会人口统计学协变量分别解释了HUI3和VAS分数中35%至55%的变异。在所有3个模型中,年龄和大多数SF-12项目与两种效用分数均显著相关(P < 0.0001)。

结论

本研究支持可以从SF-12推导出一种算法,用于在效用未直接测量或无法直接测量的人群研究中,基于HUI3和VAS估计效用分数。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验